Navigation Links
Neurosurgeons from around the world gather at PLA 301 Hospital in China
Date:4/8/2009

WINNIPEG, April 8 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") participated in China's first international conference on intra-operative MR held at PLA 301 Hospital in Beijing on April 5, 2009. Over 300 neurosurgeons from China, USA, Germany, Taiwan and Hong Kong attended the inaugural event that focused on developments in intra-operative MR for neurosurgery. The conference was opened by Dir Chen Xiaohong, Director of PLA 301, and featured scientific presentations from Peter Black, Professor of Neurosurgery, Harvard Medical School, Christopher Nimsky, Professor and Chairman of Neurosurgery, University Marburg, and Michael Buchfelder, Professor and Chairman of Neurosurgery, University of Erlangen.

The conference program included the official opening of PLA 301's IMRISneuro suite - the first-of-its-kind surgical OR with integrated intra-operative MR imaging in China. Featuring a 1.5 Tesla wide bore magnet, IMRISneuro provides the hospital's surgical team with high quality images before, during and after procedures without moving the patient. Over 150 of the conference delegates were able to observe portions of a live case tumor resection using the new system.

PLA 301's neurosurgical team completed its first procedure on February 23, 2009, and completed five procedures in the first week of operation. In the six weeks since installation of the IMRISneuro suite, the team treated 43 patients suffering with glioma or epilepsy. While PLA 301 is widely-recognized for performing at the highest of global clinical standards, Dr. Xu Bainan, Chairman of Neurosurgery, said: "IMRIS has significantly advanced our neurosurgical capabilities and the system is contributing directly to our hospital's reputation as a world-class facility."

At the conference, David Graves, President and CEO of IMRIS shared his excitement about the project. "It is an honor to have been chosen by the neurosurgical team at PLA 301", said Mr. Graves. "We are certain this technology in their hands will help continue to provide the highest quality of care for their patients."

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers. For more information, visit www.imris.com.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson neurosurgeons using new liquid treatment for wide-neck brain aneurysm
2. Expert Neurosurgeons and Neuro-oncologists to Speak at 6th Annual Brain Tumor Awareness Day Convention
3. Alarming Rise in Autism Brings Hundreds of Parents, Researchers and Clinicians Together from Around the World to Atlanta April 17-19, 2009
4. GTSI Forms Strategic Business Unit Around its Burgeoning Healthcare Solutions Practice
5. Alivemax -- A Company Releasing Supplemental Products That Will Uplift the Health, Appearance, and Confidence of Others Around the Globe
6. Precyse Solutions Adds Executives, Realigns Around Service Lines
7. PA DEP Finds Air Quality Around Schools to be Safe
8. Millions Around World to Observe Rare Disease Day
9. Univision Radio Stations Around the Country Support St. Jude Feb. 5 & 6
10. 20 MedSpa Professionals Gain Insight into MedSpa Business Turnaround Tactics
11. Borosage Urges Progressives to Rally Around Obama Economic Recovery Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Visually ... number one doctor-recommended OTC antiperspirant, Certain Dri. , Excessive sweating and hyperhidrosis are ... Dri created this infographic to explain the seven types of hyperhidrosis. This visual ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced today ... compete in the Boston Marathon on April 17. From first-time participants to accomplished ... to join Team V and support the Foundation’s mission to declare victory over cancer. ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... offering asset protection and financial planning services to families and business owners in ... event aimed at supporting children with developmental disabilities. , The Lakemary Center is ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael J. Hennessy ... for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. President Michael ... field of biosimilars through thought leader interaction in, live video and interactive digital ...
(Date:1/18/2017)... ... 18, 2017 , ... Floundering on New Year’s resolutions? Need an excuse to ... a reset. The U.S. Apple Association agrees and recommends starting each day with ... contribute to heart disease. , The U.S. Apple Association – which represents apple growers ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017  Eisai Inc., the U.S. ... that it is participating in Access Accelerated, a ... (NCDs) prevention, treatment and care in low and ... the first multi-stakeholder, international initiative in the field ... including Eisai, in collaboration with the World Bank ...
(Date:1/18/2017)... --  Robust competition in the private marketplace is resulting ... according to a new study by the ... first to examine the share of prescription medicine spending ... (PBMs), health plans and other stakeholders in the supply ... to show what happens when the list price of ...
(Date:1/17/2017)... 17, 2017 Secretary of Health Dr. ... Gary Tennis are warning Pennsylvanians of the ... overdose deaths from the drug in Beaver ... to sedate large animals and is not meant for ... into contact with it," Secretary Murphy said. "It,s absolutely ...
Breaking Medicine Technology: